Received Nov 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 1 | — | — |
After the second dose she was blind in one eye, covered with hives and had a stroke; After the second dose she was blind in one eye, covered with hives and had a stroke; After the second dose she was blind in one eye, covered with hives and had a stroke; This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (After the second dose she was blind in one eye, covered with hives and had a stroke), BLINDNESS UNILATERAL (After the second dose she was blind in one eye, covered with hives and had a stroke) and URTICARIA (After the second dose she was blind in one eye, covered with hives and had a stroke) in a 40-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received second dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, received first dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CEREBROVASCULAR ACCIDENT (After the second dose she was blind in one eye, covered with hives and had a stroke) (seriousness criteria hospitalization and medically significant), BLINDNESS UNILATERAL (After the second dose she was blind in one eye, covered with hives and had a stroke) (seriousness criteria hospitalization and medically significant) and URTICARIA (After the second dose she was blind in one eye, covered with hives and had a stroke) (seriousness criterion hospitalization). The patient was hospitalized for 14 days due to BLINDNESS UNILATERAL, CEREBROVASCULAR ACCIDENT and URTICARIA. At the time of the report, CEREBROVASCULAR ACCIDENT (After the second dose she was blind in one eye, covered with hives and had a stroke), BLINDNESS UNILATERAL (After the second dose she was blind in one eye, covered with hives and had a stroke) and URTICARIA (After the second dose she was blind in one eye, covered with hives and had a stroke) had resolved. Concomitant medication was not provided. It was reported that the patient had received two doses of the COVID-19 vaccine. It was explained that after the second dose, the patient had gone blind in one eye, had developed hives, and had suffered a stroke. She had been hospitalized for approximately two weeks. The patient was young and strong and had fully recovered. It was unknown if the patient experienced any additional symptoms or events. Treatment medication was not reported.; Reporter's Comments: The benefit-risk relationship of product is not affected by this report.